Aurobindo's subsidiary to withdraw application for EU marketing authorization of two biosimilars
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
This request for withdrawal of the two dossiers was made after necessary consultations and receiving guidance from EMA
GL0034 is a novel, investigational glucagon-like peptide 1 receptor agonist (GLP-1RA) being studied for the treatment of type 2 diabetes and obesity
Dr. Reddy's aims to roll out its trade generics across cities and towns in India
GenWorks has scaled up its e-commerce platform in terms of building traffic
Augnito’s AI comprehends all English accents with 99% accuracy
Effective disaster response and management is a collaborative work
This partnership will revolutionize Pharmarack's digital infrastructure with Snowflake's single, integrated platform to facilitate advanced analytic
Subscribe To Our Newsletter & Stay Updated